Evidence map›Paper›PMID 23103230›Full record

ArticleAmerican journal of human genetics2012

In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome.

Virginie Carmignac, Julien Thevenon, Lesley Adès, Bert Callewaert, Sophie Julia, Christel Thauvin-Robinet, Lucie Gueneau, Jean-Benoit Courcet, Estelle Lopez, Katherine Holman and 28 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 110 citations in OpenAlex.

  1. Trial
  2. Article
  3. Genetic Causes of Thoracic Aortic Aneurysm: A Review.Methodist DeBakey cardiovascular journal · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Hereditary Thoracic Aortic Diseases.Diagnostics (Basel, Switzerland) · 2024
    Review
  10. Context-dependent TGFβ family signalling in cell fate regulation.Nature reviews. Molecular cell biology · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Toward precision medicine in vascular connective tissue disorders.American journal of medical genetics. Part A · 2021
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 16 institutions in 7 countries.

Virginie CarmignacEquipe d'Accueil 4271, Equipe Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.
Julien Thevenon
Lesley Adès
Bert Callewaert
Sophie Julia
Christel Thauvin-Robinet
Lucie Gueneau
Jean-Benoit Courcet
Estelle Lopez
Katherine Holman
Marjolijn Renard
Henri Plauchu
Ghislaine Plessis
Julie De Backer
Anne Child
Gavin Arno
Laurence Duplomb
Patrick Callier
Bernard Aral
Pierre Vabres
Nadège Gigot
Eloisa Arbustini
Maurizia Grasso
Peter N Robinson
Cyril Goizet
Clarisse Baumann
Maja Di Rocco
Jaime Sanchez Del Pozo
Frédéric Huet
Guillaume Jondeau
Gwenaëlle Collod-Beroud
Christophe Beroud
Jeanne Amiel
Valérie Cormier-Daire
Jean-Baptiste Rivière
Catherine Boileau
Anne De Paepe
Laurence Faivre
Université de Bourgogne · FRGhent University Hospital · BEInserm · FRSt George's, University of London · GBThe University of Sydney · AUAssistance Publique Hôpitaux de Marseille · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Caen Normandie · FRCentre Hospitalier Universitaire de Toulouse · FRCharité - Universitätsmedizin Berlin · DEHôpital Necker-Enfants Malades · FRIstituto Giannina Gaslini · ITResearch Institute Hospital 12 de Octubre · ESUniversité Claude Bernard Lyon 1 · FRUniversité de Bordeaux · FRUniversité Paris Cité · FR

Funding

Comprehensive Sequencing and Analysis of Variation in NHLBI CohortsUC2HL102925 · NHLBI · BROAD INSTITUTE, INC. · PI ALTSHULER, DAVID, GABRIEL, STACEY · 2010 to 2010
$14.7M
Northwest Genomics CenterUC2HL102926 · NHLBI · UNIVERSITY OF WASHINGTON · PI GREEN, PHILIP P, NICKERSON, DEBORAH A · 2010 to 2010
$14.0M
Northwest Genomics CenterRC2HL102926 · NHLBI · UNIVERSITY OF WASHINGTON · PI GREEN, PHILIP P, NICKERSON, DEBORAH A · 2009 to 2009
$11.0M
Comprehensive Sequencing and Analysis of Variation in NHLBI CohortsRC2HL102925 · NHLBI · BROAD INSTITUTE, INC. · PI ALTSHULER, DAVID, GABRIEL, STACEY · 2009 to 2009
$10.2M
ARRA - NHLBI Lung Cohorts Sequencing ProjectRC2HL102923 · NHLBI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, BARNES, KATHLEEN C · 2009 to 2009
$2.6M
ARRA - NHLBI Lung Cohorts Sequencing ProjectUC2HL102923 · NHLBI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, BARNES, KATHLEEN C · 2010 to 2010
$2.6M
WHI Sequencing Project (WHISP)UC2HL102924 · NHLBI · OHIO STATE UNIVERSITY · PI CARLSON, CHRISTOPHER S, JACKSON, REBECCA D · 2010 to 2010
$2.4M
WHI Sequencing Project (WHISP)RC2HL102924 · NHLBI · OHIO STATE UNIVERSITY · PI CARLSON, CHRISTOPHER S, JACKSON, REBECCA D · 2009 to 2009
$2.1M
Human Exome Sequencing in Six Well-Phenotyped NHLBI CohortsUC2HL103010 · NHLBI · UNIVERSITY OF VIRGINIA · PI RICH, STEPHEN S. · 2010 to 2010
$1.5M
Human Exome Sequencing in Six Well-Phenotyped NHLBI CohortsRC2HL103010 · NHLBI · UNIVERSITY OF VIRGINIA · PI RICH, STEPHEN S. · 2009 to 2009
$817k
NHLBI NIH HHS HL-102923NHLBI NIH HHS HL-102924NHLBI NIH HHS HL-102925NHLBI NIH HHS HL-102926NHLBI NIH HHS HL-103010NHLBI NIH HHS RC2 HL102923NHLBI NIH HHS RC2 HL102924NHLBI NIH HHS RC2 HL102925NHLBI NIH HHS RC2 HL102926NHLBI NIH HHS RC2 HL103010NHLBI NIH HHS UC2 HL102923NHLBI NIH HHS UC2 HL102924NHLBI NIH HHS UC2 HL102925NHLBI NIH HHS UC2 HL102926NHLBI NIH HHS UC2 HL103010
6 · The paper itself

Abstract

Shprintzen-Goldberg syndrome (SGS) is characterized by severe marfanoid habitus, intellectual disability, camptodactyly, typical facial dysmorphism, and craniosynostosis. Using family-based exome sequencing, we identified a dominantly inherited heterozygous in-frame deletion in exon 1 of SKI. Direct sequencing of SKI further identified one overlapping heterozygous in-frame deletion and ten heterozygous missense mutations affecting recurrent residues in 18 of the 19 individuals screened for SGS; these individuals included one family affected by somatic mosaicism. All mutations were located in a restricted area of exon 1, within the R-SMAD binding domain of SKI. No mutation was found in a cohort of 11 individuals with other marfanoid-craniosynostosis phenotypes. The interaction between SKI and Smad2/3 and Smad 4 regulates TGF-β signaling, and the pattern of anomalies in Ski-deficient mice corresponds to the clinical manifestations of SGS. These findings define SGS as a member of the family of diseases associated with the TGF-β-signaling pathway.

Indexed as

ExonsGenes, DominantMutationAdolescentAdultAmino Acid SequenceArachnodactylyChildChild, PreschoolCraniosynostosesDNA-Binding ProteinsFaciesFemaleGene OrderHumansMaleDNA-Binding ProteinsProto-Oncogene ProteinsSKI protein, human

Identifiers

PMID23103230
PMCPMC3487125
OpenAlexW2024183174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.